PR

PainReform LtdNASDAQ PRFX Stock Report

Last reporting period 31 Dec, 2023

Updated 14 Nov, 2024

Last price

Market cap $B

0.001

Micro

Exchange

XNAS - Nasdaq

PRFX Stock Analysis

PR

Uncovered

PainReform Ltd is uncovered by Eyestock quantitative analysis.

Market cap $B

0.001

Dividend yield

Shares outstanding

10.634 B

PainReform Ltd. is a pharmaceutical company, which focuses on reformulation of established therapeutics. The Company’s main activity is to develop reformulation of established pain therapeutics. PainReform Ltd provides technology, which is dedicated to prolong and enhance efficacy, minimize adverse effects and increase patients convenience as well as faster return of motor function.

View Section: Eyestock Rating